Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Tetramyristoyl Cardiolipin
2. Tmcl Cpd
1. Tetramyristoylcardiolipin
2. Tetramyristoyl Cardiolipin
3. Chebi:62862
4. 1,1'2,2'-tetramyristoylcardiolipin
5. 1,1'2,2'-tetramyristoyl Cardiolipin
6. Tetramyristoyl-cardiolipin
7. Epitope Id:161169
8. Q27132243
9. Cl(14:0/14:0/14:0/14:0)
10. 1',3'-bis[1,2-bis(tetradecanoyl)-sn-glycero-3-phospho]-sn-glycerol
11. (17r,29r)-20,23,26-trihydroxy-20,26-dioxido-14,32-dioxo-15,19,21,25,27,31-hexaoxa-20lambda(5),26lambda(5)-diphosphapentatetracontane-17,29-diyl Ditetradecanoate
12. (2r,5r,11r,14r)-5,8,11-trihydroxy-5,11-dioxido-17-oxo-2,14-bis(tetradecanoyloxy)-4,6,10,12,16-pentaoxa-5,11-diphosphatriacont-1-yl Tetradecanoate (non-preferred Name)
13. [(2r)-3-[[3-[[(2r)-2,3-di(tetradecanoyloxy)propoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-tetradecanoyloxypropyl] Tetradecanoate
| Molecular Weight | 1241.6 g/mol |
|---|---|
| Molecular Formula | C65H126O17P2 |
| XLogP3 | 21.8 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 17 |
| Rotatable Bond Count | 70 |
| Exact Mass | 1240.84702654 g/mol |
| Monoisotopic Mass | 1240.84702654 g/mol |
| Topological Polar Surface Area | 237 Ų |
| Heavy Atom Count | 84 |
| Formal Charge | 0 |
| Complexity | 1510 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Tetramyristoylcardiolipin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tetramyristoylcardiolipin, including repackagers and relabelers. The FDA regulates Tetramyristoylcardiolipin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tetramyristoylcardiolipin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tetramyristoylcardiolipin supplier is an individual or a company that provides Tetramyristoylcardiolipin active pharmaceutical ingredient (API) or Tetramyristoylcardiolipin finished formulations upon request. The Tetramyristoylcardiolipin suppliers may include Tetramyristoylcardiolipin API manufacturers, exporters, distributors and traders.
click here to find a list of Tetramyristoylcardiolipin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tetramyristoylcardiolipin DMF (Drug Master File) is a document detailing the whole manufacturing process of Tetramyristoylcardiolipin active pharmaceutical ingredient (API) in detail. Different forms of Tetramyristoylcardiolipin DMFs exist exist since differing nations have different regulations, such as Tetramyristoylcardiolipin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tetramyristoylcardiolipin DMF submitted to regulatory agencies in the US is known as a USDMF. Tetramyristoylcardiolipin USDMF includes data on Tetramyristoylcardiolipin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tetramyristoylcardiolipin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tetramyristoylcardiolipin suppliers with USDMF on PharmaCompass.
Tetramyristoylcardiolipin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tetramyristoylcardiolipin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tetramyristoylcardiolipin GMP manufacturer or Tetramyristoylcardiolipin GMP API supplier for your needs.
A Tetramyristoylcardiolipin CoA (Certificate of Analysis) is a formal document that attests to Tetramyristoylcardiolipin's compliance with Tetramyristoylcardiolipin specifications and serves as a tool for batch-level quality control.
Tetramyristoylcardiolipin CoA mostly includes findings from lab analyses of a specific batch. For each Tetramyristoylcardiolipin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tetramyristoylcardiolipin may be tested according to a variety of international standards, such as European Pharmacopoeia (Tetramyristoylcardiolipin EP), Tetramyristoylcardiolipin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tetramyristoylcardiolipin USP).
LOOKING FOR A SUPPLIER?
